Once the normal cells such as the endothelial cells and cancer-associated fibroblasts exposed to chemotherapeutics, these cells would express a high level of pro-inflammatory molecules such as interleukin-6 (IL-6) and IL-8 to recruit immunosuppressive cells and therefore lead to the suppression of anti-tumor immune response. Here, IL6 is linked to cancer.